|
|
Article: Buprenorphine may not be 'the latest' for long: more Rx options could help build office-based treatment of opiate addiction.
- Article from:
- Addiction Professional
- Article date:
- July 1, 2005
- Author:
CopyrightCOPYRIGHT 2005 Vendome Group LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Charles R. Schuster, Ph.D., director of the substance abuse division at Wayne State University's medical school, runs a survey funded in response to congressional concern that buprenorphine, the newest medication available in the U.S. to treat opiate addiction, might be subject to diversion.
[ILLUSTRATION OMITTED]
More than two years after the medication's introduction, about 99 percent of the diversion Schuster finds involves people who buy buprenorphine on the street--not to get high, but to try it as medication for their addiction. Apparently, they have heard it works.
By all accounts, the landmark change heralded by buprenorphine's ...